Literature DB >> 8091777

Lymph node dissection.

T P Hennessy1.   

Abstract

Cervical lymph nodes are involved in 43% of patients with an upper esophageal lesion, 33% of patients with a middle third tumor, and 29% with a tumor of the lower third. Conventional two-field lymph node dissection removing the abdominal and lower mediastinal lymph node groups leads to inaccurate staging and is inadequate for preventing local recurrence. Three-field lymphadenectomy involves bilateral removal of the lower cervical groups of nodes, the superior, middle, and inferior mediastinal lymph nodes and the abdominal groups. The advantages of this extended dissection are improved survival, diminished incidence of local recurrence, and more accurate staging. The benefits in terms of improved survival may accurate to patients both with and without cervical lymph node involvement. Three-field node dissection improves 5-year survival to around 35% without an increase in the mortality rate. The incidence of recurrent laryngeal nerve paralysis is increased with the operation and could be as high as 14% or more.

Entities:  

Mesh:

Year:  1994        PMID: 8091777     DOI: 10.1007/bf00316816

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  11 in total

Review 1.  Surgical therapy of oesophageal carcinoma.

Authors:  J M Müller; H Erasmi; M Stelzner; U Zieren; H Pichlmaier
Journal:  Br J Surg       Date:  1990-08       Impact factor: 6.939

2.  Evaluation of neck lymph node dissection for thoracic esophageal carcinoma.

Authors:  H Kato; H Watanabe; Y Tachimori; T Iizuka
Journal:  Ann Thorac Surg       Date:  1991-06       Impact factor: 4.330

3.  Results of a nationwide study on the three-field lymph node dissection of esophageal cancer.

Authors:  K Isono; H Sato; K Nakayama
Journal:  Oncology       Date:  1991       Impact factor: 2.935

4.  Lymph node metastasis in thoracic esophageal carcinoma.

Authors:  H Kato; Y Tachimori; H Watanabe; T Iizuka; S Terui; M Itabashi; T Hirota
Journal:  J Surg Oncol       Date:  1991-10       Impact factor: 3.454

5.  Carcinoma of thoracic oesophagus and cardia. A review of 405 cases.

Authors:  C MILLER
Journal:  Br J Surg       Date:  1962-03       Impact factor: 6.939

6.  Quality of life and patterns of recurrence following transhiatal esophagectomy for cancer: results of a prospective follow-up in 50 patients.

Authors:  P A Barbier; P J Luder; G Schüpfer; C D Becker; H E Wagner
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

7.  Lymph node metastasis in resectable esophageal cancer.

Authors:  S Abe; M Tachibana; M Shiraishi; T Nakamura
Journal:  J Thorac Cardiovasc Surg       Date:  1990-08       Impact factor: 5.209

8.  Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus.

Authors:  M B Orringer
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

9.  Treatment of carcinoma of the esophagus. Retrospective study of 2,400 patients.

Authors:  R Giuli; M Gignoux
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

10.  En bloc resection for neoplasms of the esophagus and cardia.

Authors:  D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

View more
  2 in total

1.  Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy.

Authors:  Tatsuya Miyazaki; Hiroyuki Kuwano; Hiroyuki Kato; Minako Yoshikawa; Hitoshi Ojima; Katsuhiko Tsukada
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

2.  Construction of a Diagnostic Model for Lymph Node Metastasis of the Papillary Thyroid Carcinoma Using Preoperative Ultrasound Features and Imaging Omics.

Authors:  Chao Zhang; Lihua Cheng; Weiwen Zhu; Jian Zhuang; Tong Zhao; Xiaoqin Li; Wenfeng Wang
Journal:  J Healthc Eng       Date:  2022-02-08       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.